Lusek Medicare Private Limited
About Lusek Medicare Private Limited
Data last updated:
Lusek Medicare Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U62013MH2019PTC334561. Its GSTIN is 09AAECL1050G1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Archana Gupta and Narender Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹8.21 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹73,296 (net margin -8.9%) and EBITDA of -₹47,360 (EBITDA margin -5.8%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Lusek Medicare Private Limited
The main business activity of Lusek Medicare is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Lusek Medicare Private Limited FY 2025 filings available
Lusek Medicare Private Limited reported revenue of ₹8.21 Lakh (up 932% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Lusek Medicare Private Limited
Revenue rose 932% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Lusek Medicare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹47,360 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹73,296 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Lusek Medicare Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -8.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Lusek Medicare are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Lusek Medicare Private Limited
Lusek Medicare Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Calynn Formulations Private Limited | ₹8.34 Lakh (FY 2025) | •••• | •••• | 74.0% | •••• | Hyderabad, Telangana, India |
| Richmond Biosciences Private Limited | ₹8.29 Lakh (FY 2022) | •••• | •••• | -69.0% | •••• | Secunderabad, Telangana, India |
| Letos Lifesciences Private Limited | ₹8.28 Lakh (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Hamara Remedies Private Limited | ₹8.24 Lakh (FY 2024) | •••• | •••• | -39.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Cam Neuro Pharma Private Limited | ₹8.21 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | Cuttack Sadar, Odisha, India |
| Lusek Medicare Private Limited this company | ₹8.21 Lakh (FY 2025) | •••• | •••• | 932.0% | •••• | Mumbai, Maharashtra, India |
| Ebullient Pharmaceuticals Private Limited | ₹8.17 Lakh (FY 2025) | •••• | •••• | -25.0% | •••• | Satara, Maharashtra, India |
| Kapynag Pharma Private Limited | ₹8.16 Lakh (FY 2025) | •••• | •••• | -96.0% | •••• | Nashik, Maharashtra, India |
| Ellia Cytocare Private Limited | ₹8.12 Lakh (FY 2025) | •••• | •••• | -51.0% | •••• | Chauhan Patti, Delhi, India |
| Vijay Shree Chem Drugs Private Limited | ₹8.12 Lakh (FY 2025) | •••• | •••• | -11.0% | •••• | Uttar Pradesh, India |
| PRK Pharmanlysts Private Limited | ₹8.07 Lakh (FY 2024) | •••• | •••• | 22.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Lusek Medicare by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Lusek Medicare Private Limited
Lusek Medicare has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Archana Gupta | Director | 17 Dec 2019 | 6 Years 9 Months | Current |
| Narender Kumar | Director | 17 Dec 2019 | 6 Years 9 Months | Current |
| Ajai Kumar Srivastava | Director | 02 Aug 2025 | 1 Years 2 Months | Current |
Charges & Borrowings of Lusek Medicare Private Limited
Lusek Medicare Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Lusek Medicare Private Limited
Employment history and EPFO contributions of people linked to Lusek Medicare.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Lusek Medicare Private Limited
Lusek Medicare has one previous CIN (Corporate Identification Number): U24290MH2019PTC334561. The current CIN is U62013MH2019PTC334561, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U62013MH2019PTC334561 | Current |
| U24290MH2019PTC334561 | Previous |
Recent Activity on Lusek Medicare Private Limited
Lusek Medicare Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Ajai Kumar Srivastava was appointed as Director on 02 Aug 2025.
Credit Ratings, Litigation & Regulatory Alerts for Lusek Medicare Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Lusek Medicare Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Lusek Medicare Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Lusek Medicare Private Limited
Lusek Medicare has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECL1050G1ZT | Uttar Pradesh | Active | 02 Jan 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Lusek Medicare Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lusek Medicare Private Limited
Lusek Medicare is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 December 2019 (7+ years old) and is registered under CIN U62013MH2019PTC334561.
Lusek Medicare reported revenue of ₹8.21 Lakh for FY 2025 (up 932% YoY).
Lusek Medicare has 3 current directors:
- Archana Gupta - Director
- Narender Kumar - Director
- Ajai Kumar Srivastava - Director
Lusek Medicare reported a net loss of ₹73,296 (net margin -8.9%) and EBITDA of -₹47,360 (EBITDA margin -5.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Lusek Medicare is -12% over three years. In the latest year (FY 2025) revenue rose 932%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Lusek Medicare is 09AAECL1050G1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Lusek Medicare is U62013MH2019PTC334561. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lusek Medicare was incorporated on 17 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Lusek Medicare by revenue are Calynn Formulations Private Limited, Richmond Biosciences Private Limited, Letos Lifesciences Private Limited, Hamara Remedies Private Limited, Cam Neuro Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Ajai Kumar Srivastava was appointed as Director on 02 Aug 2025. Archana Gupta was appointed as Director on 17 Dec 2019. Narender Kumar was appointed as Director on 17 Dec 2019.
The registered office of Lusek Medicare is at Sarbat Ali Chawl Room No1 Jamil Ngr Rd Bhandup, Mumbai, Maharashtra, India – 400078.